Thanks to @shahida for alerting me to this. K-PAX Pharmaceuticals Inc. are in the Chase Mission Main Street charity voting contest and say: I believe they're referring to the Synergy Trial of KPAX 002, a combination of an immune modulator with methylphenidate (ritalin). Their Product Pipeline page says: You can vote from anywhere in the world. To vote (you must have a Facebook account), go here: https://www.missionmainstreetgrants.com/business/detail/52189 They've got 8 votes so far. They need 250 unique votes by Oct 17 (argh, Friday!) to be in with a shot at $150,000. So, vote once, you're done! Thereafter, it's up to a panel of judges. Let's get voting!